[

rdif

]
A medical worker fills a syringe with Sputnik V (Gam-COVID-Vac) vaccine as she prepares to vaccinate a Russian Army service member at a clinic in the city of Rostov-On-Don, Russia.(REUTERS)

Russia to trial combined AstraZeneca, Sputnik V vaccine in Ukraine

By Reuters | Moscow
UPDATED ON JAN 03, 2021 09:02 AM IST
Russia’s sovereign RDIF announced in December trials to test a combination of the AstraZeneca vaccine with the Sputnik V shot to see if this can boost the efficacy of the British drugmaker’s vaccine.
Close
A Russian medical worker prepares a shot of Russia's Sputnik V coronavirus vaccine in Moscow on Thursday, Dec. 10, 2020 (AP Photo/Pavel Golovkin)
A Russian medical worker prepares a shot of Russia's Sputnik V coronavirus vaccine in Moscow on Thursday, Dec. 10, 2020 (AP Photo/Pavel Golovkin)

India to make 300 million doses of Sputnik V in 2021, says Russian Direct Investment Fund chief

By hindustantimes.com | Edited by Karan Manral | Hindustan Times, New Delhi
UPDATED ON DEC 18, 2020 03:30 PM IST
The Russian Direct Investment Fund (RDIF) has partnered with Dr. Reddy’s Laboratories Limited and pharma firm Hetero for clinical trials and distribution of the Russian Covid-19 vaccine in India.
Close
According to the survey results, 73% of the 12,000 respondents from 11 countries, was willing to be vaccinated against the viral disease, while of those aware of Russia’s Sputnik V vaccine and willing to be vaccinated, the number was even higher – four out of every five respondents.(AP File)
According to the survey results, 73% of the 12,000 respondents from 11 countries, was willing to be vaccinated against the viral disease, while of those aware of Russia’s Sputnik V vaccine and willing to be vaccinated, the number was even higher – four out of every five respondents.(AP File)

About 80% Indians surveyed want anti-Covid-19 vaccine shot: RDIF

By HT Correspondent | Edited by Zara Khan | Hindustan Times, New Delhi
UPDATED ON NOV 18, 2020 09:06 AM IST
The RDIF survey found 60% of the respondents were aware of the Russian vaccine – the highest awareness level among the countries that participated in the survey, on par with respondents from Mexico
Close
Large-scale trials of the Sputnik V vaccine in India were first announced and then knocked back by Indian regulators.(Unsplash)
Large-scale trials of the Sputnik V vaccine in India were first announced and then knocked back by Indian regulators.(Unsplash)

Russia receives renewed approval for Covid-19 vaccine trials in India: RDIF

By Reuters | Posted by Jahnavi Gupta | Moscow
UPDATED ON OCT 18, 2020 04:09 PM IST
The Russian Direct Investment Fund (RDIF) and Dr Reddy’s Laboratories Ltd have received renewed approval to conduct late-stage clinical trials in India of the Russian Covid-19 vaccine.
Close
A vial of the 'Gam-COVID-Vac', also known as 'Sputnik V', COVID-19 vaccine, developed by the Gamaleya National Research Center for Epidemiology and Microbiology and the Russian Direct Investment Fund (RDIF), sits alongside a syringe in a kidney dish, ready for administration during a post-registration phase trial at the City Clinic #46 in Moscow, Russia.(Bloomberg)
A vial of the 'Gam-COVID-Vac', also known as 'Sputnik V', COVID-19 vaccine, developed by the Gamaleya National Research Center for Epidemiology and Microbiology and the Russian Direct Investment Fund (RDIF), sits alongside a syringe in a kidney dish, ready for administration during a post-registration phase trial at the City Clinic #46 in Moscow, Russia.(Bloomberg)

Production hurdles hurt Russia’s Covid-19 vaccine targets

By Bloomberg | Posted by Shankhyaneel Sarkar
UPDATED ON OCT 15, 2020 12:01 PM IST
With a second wave of coronavirus cases sweeping Russia, the Kremlin needs the vaccine as it battles rising daily infection rates while seeking to avoid a repeat of a nationwide lockdown in the spring that battered the country’s economy.
Close
The Russian Direct Investment Fund (RDIF), the state sovereign wealth fund backing the vaccine’s development, signed its first export deal with Kazakhstan in August.(REUTERS)
The Russian Direct Investment Fund (RDIF), the state sovereign wealth fund backing the vaccine’s development, signed its first export deal with Kazakhstan in August.(REUTERS)

Russia’s RDIF to sell 32 million Covid-19 vaccine doses to Mexico firm: Reports

By Reuters| Posted by Susmita Pakrasi | Moscow
PUBLISHED ON SEP 09, 2020 02:49 PM IST
Russia registered its first vaccine candidate, developed by Moscow’s Gamaleya Institute, in August. Late-stage trials of Sputnik-V, due to involve 40,000 participants, were launched on August 26.
Close
SHARE
Story Saved